Singapore, Singapore

Jayaganesh V Natarajan

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Jayaganesh V Natarajan

Introduction

Jayaganesh V Natarajan is a notable inventor based in Singapore, recognized for his contributions to ocular drug delivery systems. He holds three patents that showcase his innovative approach to treating anterior segment eye diseases.

Latest Patents

One of his latest patents is titled "Nanoliposomes for sustained delivery of tacrolimus for treatment of anterior segment eye diseases." This invention involves the use of nanoliposomes that encapsulate tacrolimus, a hydrophobic drug, within lipid bilayers. The formulation aims to provide effective prophylaxis and treatment for anterior segment ocular diseases. Another significant patent is the "Liposomal formulation for ocular drug delivery," which focuses on a liposomal formulation that includes a prostaglandin drug. This formulation is designed to enhance the delivery of ocular medications, ensuring better treatment outcomes for patients.

Career Highlights

Jayaganesh has worked with esteemed institutions such as Nanyang Technological University and Singapore Health Services Pte Ltd. His work in these organizations has contributed to advancements in medical technology and drug delivery systems.

Collaborations

He has collaborated with notable professionals in his field, including Subramanian Venkatraman and Yin Chiang Freddy Boey. These collaborations have further enriched his research and development efforts.

Conclusion

Jayaganesh V Natarajan's innovative work in ocular drug delivery systems highlights his significant contributions to the field of medicine. His patents reflect a commitment to improving treatment options for patients with eye diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…